Alistair R Miller (Alistair Miller)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 8

Top Topics

Top Venues

Respirology (Carlton, Vic.)

This page only lists publications with an associated author ORCID identifier.

Publications

Alistair R Miller
Checkpoint inhibitors are a basic science-based, transformative new treatment for lung cancer. Respirology (Carlton, Vic.) 28 (2) (2022)
Alistair R Miller
Checkpoint inhibitors are a basic science-based, transformative new treatment for lung cancer. Respirology (Carlton, Vic.) 28 (2) (2022)
Alistair R Miller
Checkpoint inhibitors are a basic science-based, transformative new treatment for lung cancer. Respirology (Carlton, Vic.) (2022)
Alistair R Miller
Checkpoint inhibitors are a basic science-based, transformative new treatment for lung cancer. Respirology (Carlton, Vic.) 28 (2) (2022)
Alistair R Miller, Emily Stone
Essential update in lung cancer medicine. Respirology (Carlton, Vic.) (2020)
Christine Faye McDonald, Stuart Jones, Lutz Beckert, Billie Bonevski, Tanya Buchanan, Jack Bozier, Kristin V Carson-Chahhoud, David G Chapman, Claudia Caroline Dobler, Juliet M Foster, Paul Hamor, Sandra Hodge, Peter W Holmes, Alexander N Larcombe, Henry M Marshall, Gabrielle Britt McCallum, Alistair R Miller, Philip Pattemore, Robert Roseby, Hayley V See, Emily Stone, Bruce R Thompson, Miranda P Ween, Matthew J Peters
Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand. Respirology (Carlton, Vic.) 25 (10) (2020)
Emily Stone, Nicole Rankin, Jane Phillips, Kwun Fong, David C Currow, Alistair R Miller, Geraldine Largey, Robert Zielinski, Peter Flynn, Tim Shaw
Consensus minimum data set for lung cancer multidisciplinary teams: Results of a Delphi process. Respirology (Carlton, Vic.) 23 (10) (2018)
Alistair R Miller
Multiple sub-solid nodules: Different or just more? Respirology (Carlton, Vic.) 22 (8) (2017)